Document Detail


Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction.
MedLine Citation:
PMID:  21519201     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The metabolic syndrome is a common disorder characterized by central (especially intra-abdominal) obesity, hypertension, impaired glucose tolerance and atherogenic dyslipidemia (including the combination of hypertriglyceridemia and low levels of high-density lipoprotein cholesterol). In this article, the authors review interventions to improve this lipid profile and potentially reduce the risk of major cardiovascular events in patients with metabolic syndrome.
Authors:
Carl J Lavie; Richard V Milani; James H O'keefe
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of the medical sciences     Volume:  341     ISSN:  1538-2990     ISO Abbreviation:  Am. J. Med. Sci.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370506     Medline TA:  Am J Med Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  388-93     Citation Subset:  AIM; IM    
Affiliation:
From the Department of Cardiovascular Diseases (cjl, rvm), John Ochsner Heart and Vascular Institute, Ochsner Clinical School, the University of Queensland School of Medicine, New Orleans, Louisiana; and Mid America Heart Institute (jhk), University of Missouri, Kansas City, Missouri.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low colorectal anastomosis after pelvic exenteration for gynecologic malignancies: risk factors anal...
Next Document:  The development of nurse executive leadership: an interview with marjorie beyers.